Objective: To evaluate associations between components of the Mediterranean diet and circulating markers of inflammation in a large cohort of asymptomatic subjects at high risk for cardiovascular disease. Subjects/Methods: A total of 339 men and 433 women aged between 55 and 80 years at high cardiovascular risk because of presence of diabetes or at least three classical cardiovascular risk factors, food consumption was determined by a semiquantitative food frequency questionnaire. Serum concentrations of high-sensitivity C-reactive protein (CRP) were measured by immunonephelometry and those of interleukin-6 (IL-6), intracellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) by enzyme-linked immunosorbent assay. Results: After adjusting for age, gender, body mass index, diabetes, smoking, use of statins, non-steroidal antiinflammatory drugs and aspirin, a higher consumption of fruits and cereals was associated with lower concentrations of IL-6 (P for trend 0.005;both). Subjects with the highest consumption of nuts and virgin olive oil showed the lowest concentrations of VCAM-1, ICAM-1, IL-6 and CRP; albeit only for ICAM-1 was this difference statistically significant in the case of nuts (for trend 0.003) and for VCAM-1 in the case of virgin olive oil (P for trend 0.02). Participants with higher adherence to the Mediterranean-type diet did not show significantly lower concentrations of inflammatory markers (Po0.1 for VCAM-1 and ICAM-1).
Introduction
Chronic inflammation has been implicated in the aetiology and development of atherosclerosis, insulin resistance and type II diabetes (Ross, 1999; Pradham and Ridker, 2002; Libby et al. , 2002; Koh et al., 2005; Haffner, 2006) . Peripheral inflammatory markers such as C-reactive protein (CRP), erythrocyte sedimentation rate, interleukin-6 (IL-6), fibrinogen and intracellular adhesion molecule-1 (ICAM-1) have been identified as independent predictors of diabetes and coronary heart disease (CHD) in recent prospective cohort studies (Harris et al., 1999; Danesh et al., 2000 Danesh et al., , 2004 Malik et al., 2001; Ridker, 2004) . Recently, the results of clinical and epidemiological studies have suggested that inflammation can be modulated by dietary factors (Estruch et al., 2004; Ros et al., 2004; Fung et al., 2005; Miles et al., 2005; Schulze et al., 2005; Jensen et al., 2006) . Among them, mono-and polyunsaturated fatty acids, o-3 fatty acids, dietary fibre, antioxidants and other phytochemicals, and L-arginine have been identified as factors capable of modulating inflammatory responses (Devaraj and Jialal, 2000; Mori et al., 2003; Ajani et al., 2004; Ló pez-García et al., 2004; Paschos et al., 2004; Zhao et al., 2004; Wells et al., 2005 , Ma et al., 2006 .
The traditional Mediterranean-type diet, rich in virgin olive oil, nuts, vegetables, legumes, fruit and fish, low in meat and processed foods and moderate in dairy products, may be a good source of these inflammation-modulating nutrients (Trichopoulou and Lagiou, 1997) .
This dietary pattern is associated with a low risk for cardiovascular disease and all-cause mortality (Knoops et al., 2003; Trichopoulou et al., 2003 Trichopoulou et al., , 2005 . In addition, a significant reduction in CHD mortality has been observed in a secondary prevention trial in patients who followed a Mediterranean-type diet (De Lorgeril et al., 1994) . Some (Chrysohoou et al., 2004; Esposito et al., 2004) but not all (Michalsen et al., 2006) studies have suggested that the low cardiovascular risk associated with the Mediterranean-type diet could be mediated in part by inflammation-related factors. Thus, adherence to the Mediterranean diet, was associated with lower concentrations of CRP, IL-6, fibrinogen and white blood cells in a cross-sectional study in Greece (Chrysohoou et al., 2004) and a decrease of inflammatory markers was observed in patients with the metabolic syndrome advised on a Mediterranean-type diet in a 2-year trial (Esposito et al., 2004) . However, no effect of this type of dietary pattern on inflammatory markers was observed in patients with established coronary disease (Michalsen et al., 2006) .
The aim of the present study was to evaluate the relationships between Mediterranean-type dietary habits and serum inflammatory and endothelial markers such as CRP, IL-6, ICAM-1 and vascular cell adhesion molecule-1 (VCAM-1).
Materials and methods

Study design
The present investigation is a cross-sectional analysis performed in the first 772 participants who were recruited into the PREDIMED trial. The details of this trial have been reported elsewhere (Estruch et al., 2006) . The Institutional Review Board of each participating centre approved the study protocol.
From October 2003 to March 2004, potential participants (n ¼ 930) were selected by physicians in primary care centres (PCC) affiliated with the 10 teaching hospitals in Spain participating in the study. Eligible subjects were communitydwelling people (age 55-80 years of age for men; 60-80 years of age for women) who fulfilled at least one of two criteria: type II diabetes and three or more CHD risk factors. The diabetes criterion was defined as a previous diagnosis of non-insulin-dependent diabetes, or fasting plasma glucose concentration X120 mg/dl observed on two consecutive occasions. The CHD risk-factor criteria included current smoking, hypertension (blood pressure 4140/90 mm Hg, or treatment with antihypertensive drugs), low-density lipoprotein (LDL) cholesterol X160 mg/dl (or treatment with hypolipidaemic drugs), low high-density lipoprotein (HDL) cholesterol p40 mg/dl, body mass index (BMI) X25 kg/m 2 , or family history of premature CHD. Exclusion criteria were previous history of cardiovascular disease, any severe chronic illness, drug or alcohol abuse, and history of allergy or intolerance to olive oil or nuts.
Participants and recruitment
The primary-care physicians based participant selection on a review of the patient's clinical record, and a screening visit. A list of candidates was obtained from computer-based records of patients regularly attending each of the participating centres.
Potentially eligible candidates were contacted by telephone and invited to attend a screening visit. The visit included an interview and filling of a 26-item questionnaire inquiring about medical conditions and risk-factor status related to eligibility. This assessment included a review of the latest electrocardiogram available from the subject's clinical notes. Ninety-five per cent of eligible candidates who met entry requirements signed the informed consent to participate in the study.
Measurements
The baseline examination included assessment of standard cardiovascular risk factors, medication use and socio-demographic factors. Height and weight were measured with light clothing and no shoes. BMI was calculated as the weight (in kg) divided by height (in m 2 ). Blood pressure was measured by trained personnel using a validated semi-automatic oscillometre (Omron HEM-70CP; Hoofddrop, the Netherlands) with the subject seated, following the procedures recommended by the Spanish Hypertension Society (Redon and Coca, 2003) . Measurements were carried out in triplicate with a 5-minute interval between each, and the mean of these values was recorded.
Food consumption was determined by a previously validated semi-quantitative 137-item food frequency questionnaire (FFQ) (Martín-Moreno et al., 1993) , and energy and nutrient intake were calculated from Spanish food composition tables (Mataix et al., 2003) . The baseline examination included the administration of a 14-item questionnaire indicating the degree of adherence to the traditional Mediterranean diet that is an extension of a previously validated questionnaire (Martínez-González et al., 2004) . Values of 0 or 1 were assigned to each of 14 dietary components. Subjects whose consumption of the 'beneficial' foods (olive oil, vegetables, legumes, fruits, nuts, fish and seafood, white meats instead of red meats, home-made sauces, red wine) was below a prespecified value were assigned a value of 0 and those above this pre-specified value were assigned a value of 1. Conversely, subjects whose consumption of 'detrimental' foods (red meats, fat-rich dairy products, commercial pastries and snacks, artificially sweetened beverages) was above a pre-specified value were assigned a value of 0 and a value of 1 if the values were below the pre-specified cutoff point. The cutoff point of each specified item was established in accordance with the results of a case-control study that evaluated the risk of first non-fatal myocardial infarction (Fernández-Jarne et al., 2002; Martínez-González et al., 2004) .
Dyslipidaemia was defined according to the third report of the National Cholesterol Education Program (ATP III) when participants had two or more of the following criteria: LDL cholesterol 4160 mg/dl, HDL cholesterol o40 mg/dl, triglycerides 4150 mg/dl, or a previous diagnosis of dyslipidaemia.
Fasting blood samples were obtained, preserved at 41C for o1 h during transportation, and stored at À801C until required for biochemical analyses. Measurements of CRP, IL-6, VCAM-1 and ICAM-1 were centralized. Serum concentrations of high-sensitivity CRP were measured by particleenhanced immunonephelometry. The lower limit of detection for this assay was 0.1 mg/l. Inter-and intra-assay coefficients of variation (CV) were 1.8 and 0.9%, respectively. Soluble ICAM-1, VCAM-1 and IL-6 were measured in duplicate using standard enzyme-linked immunosorbent assay assays. Intra-and inter-assay CVs for ICAM-1, VCAM-1 and IL-6 ranged between 1.8 and 5.4% and between 0.9 and 9.9%, respectively.
Statistical analysis
Since the concentrations of CRP and other inflammation markers had a skewed distribution, the values were transformed to their natural logarithm before statistical analyses.
To assess the associations between the consumption of selected food items or food groups and the serum concentration of inflammation markers, we categorized the participants by tertiles of food-group consumption. Means and standard deviations (s.d.) were calculated for each inflammatory marker within each tertile of food groups, or selected food items. The same procedures were performed on the score indicating the level of participant's adherence to the Mediterranean-type diet.
Values are presented as unadjusted means and s.d. and 95% confidence interval (CI). For statistical testing, the values were adjusted for potential confounding variables using ordinary least-squares regression models. Log-transformed values of inflammation markers were used as the dependent variables and food consumption as the independent variables (using two dummy variables for the second and third tertile of consumption of each food group or food item). Data in the models were controlled for age (continuous), gender, BMI (continuous), smoking (three categories) and diabetes (yes/no). Linear trends were tested using the median of each tertiles as a continuous variable after adjusting for the confounding variables mentioned above. Further analyses were performed controlling for use of statins, non-steroidal anti-inflammatory agents and aspirin before and after excluding participants with levels of inflammatory markers above the 95th percentile. All statistical analyses were performed with the SPSS package, version 12.0 (SPSS, Chicago, IL, USA). All tests were two-tailed and P-values o0.05 were considered statistically significant.
Results
Of the 930 eligible subjects, 158 were excluded (86 subjects did not meet inclusion criteria, 33 chose not to participate, and the rest had one or more exclusion criteria). Table 1 summarizes the baseline characteristics of the 772 participants (339 men and 433 women) included in the study; 697 were Europeans of Spanish descent and 75 subjects were Hispanic immigrants from Central and South America. On average, the subjects in the population sample had three cardiovascular risk factors at the time of entry into the study.
Of the total population, 88.3, 78.4 and 62.4% were overweight or obese, hypertensive, or dyslipidaemic, respectively. Of note was that, 60.8% of men and 49.7% of women in the cohort had type II diabetes.
The food pattern was characterized by a high contribution of fat-to-total caloric intake, especially in the form of monounsaturated fatty acids (MUFA). Virgin olive oil and nuts rich in MUFA were the greatest contributors to total fat intake. There was a high consumption of fish, vegetables and fruits, as is commonly observed in the Mediterranean countries.
The measured concentrations of peripheral markers of inflammation categorized according to tertiles of food group consumption are shown in Table 2 . A higher consumption of cereals and fruit was associated with lower concentrations of IL-6 (7.03, 6.01 and 6.21, and 6.00, 5.50 and 5.73 for tertiles 1, 2 and 3, for cereals and fruit, respectively; P for trend 0.01; all). In addition, a higher consumption of nuts and virgin olive oil was associated with lower concentrations of VCAM-1, ICAM-1, IL-6 and CRP; albeit only for ICAM-1 was this difference statistically significant in the case of nuts (287, 268 and 238 for tertiles 1, 2 and 3 of nut consumption, respectively; P for trend 0.003) and for VCAM-1 in the case of virgin olive oil (1138, 1163 and 997 for tertiles 1, 2 and 3 for virgin olive oil consumption, respectively; P for trend 0.02). Unexpectedly, a higher intake of dairy products was associated with lower concentrations of CRP and ICAM-1 (3.40, 3.56 and 2.89, and 275, 255, 258, for tertiles 1, 2 and 3 respectively; P for trend 0.05; all). Table 3 summarizes the concentrations of inflammatory markers in relation to the score indicating the level of adherence to the Mediterranean-type diet. Overall, participants with higher adherence to the Mediterranean diet (score 410) tended to have lower serum concentration of inflammatory biomarkers compared to those with low adherence to this dietary pattern (score o7), although the differences did not reach statistical significance (Po0.1 for ICAM-1 and VCAM-1). When participants with concentrations of inflammation markers above the 95th percentile were excluded from the analysis, no significant changes in the P-values of the overall analysis were observed.
Discussion
The overall analysis of the results of this cross-sectional study shows a significant relationship between higher consumption of some typical Mediterranean foods and lower concentrations of circulating inflammatory markers. Thus, participants in the upper tertiles of consumption of cereals, fruit, nuts and virgin olive oil tended to have lower serum concentrations of inflammatory markers, especially those related to endothelial function, after adjustment for various confounders.
Nuts and olive oil are essential constituents of the traditional Mediterranean diet. Virgin olive oil, a rich source of MUFA, is the principal source of visible fat in the diet of Mediterranean populations. Virgin olive oil retains all the lipophilic components of the olive fruit, small amounts of a-tocopherol, phytosterols, carotenoids and a considerable amount of phenolic compounds with strong antioxidant and anti-inflammatory properties (Vissers et al., 2004; Fitó et al., 2005; Pérez-Jiménez et al., 2005) . The refining process depletes the olive oil of most of these anti-inflammatory compounds. A protective effect against inflammation has been demonstrated in different models following the administration of olive oil with a high phenolic content (Martínez-Dominguez et al., 2001) . Recently, phenolic compounds derived from extra virgin oil were shown to decrease inflammatory mediator production in human whole-blood cultures (Miles et al., 2005) and to inhibit endothelial adhesion molecule expression in vitro (Carluccio , 2003) . These processes can explain, at least in part, the protection against atherosclerosis that is thought to be conferred by the Mediterranean-type pattern of food intake. In Mediterranean countries, nuts have been present in moderate quantities in the standard diet since antiquity. Nuts are rich in unsaturated fatty acids (Kris-Etherton et al., 1999) and, besides having favourable fatty-acid profiles, are a good source of bioactive compounds with potential benefits against cardiovascular disease. Nuts are rich in fibre (SalasSalvadó et al., 2006) , phenolic compounds and other antiinflammatory and antioxidant molecules (Blomhoff et al., 2006) . Also, nuts contain sizeable amounts of L-arginine, a precursor of the endogenous vasodilator nitric oxide (Cooke et al., 1993; Fitzpatrick et al., 1999) . Walnuts differ from all other nuts by having a high a-linolenic acid content (Ros and Mataix 2006) , which also has anti-inflammatory properties (Paschos et al., 2004; Zhao et al., 2004) . Similar to the findings of the present study, a high consumption of nuts and seeds has been recently shown to be associated with lower concentrations of inflammatory markers in the MultiEthnic Study of Atherosclerosis (MESA) atherosclerosis study (Jiang et al., 2006) . Decreases in inflammatory markers (Zhao et al., 2004) and improvement in endothelial function (Ros et al., 2004) have been reported in clinical trials of nut consumption. This mechanism has been proposed as a potential explanation for the established cardioprotective effect of frequent nut intake (Nash and Westpfal, 2005) .
In the present study, we observed a significant inverse association between cereal and fruit consumption and serum IL-6 concentrations. There is a lack of consensus in the literature with regard to the anti-inflammatory effects of cereals and fibre. Results from two epidemiological studies indicated that dietary fibre intake was inversely associated with serum CRP concentrations (Ajani et al., 2004; Ma et al., 2006) , but another large study failed to find any association between whole-grain intake and plasma CRP, IL-6 or fibrinogen concentrations (Jensen et al., 2006) . Also, there are increasing evidences with respect to the anti-inflammatory properties of fruit intake. Fruit and vitamin C intakes have been inversely associated with lower concentrations of circulating inflammatory markers (Wannamethee et al., 2006) , and a high intake of fruit and vegetables for a 4-week period was recently associated with a significant decrease in CRP serum concentrations (Watzl et al., 2005) .
Finally, we observed an unexpected inverse relationship between a higher consumption of dairy products and lower levels of ICAM-1 and CRP. In the last decade, dairy consumption has been inversely related to BMI, insulin resistance or diabetes and hypertension (Pereira et al., 2002; Alonso et al., 2005; Choi et al., 2005; Steffen et al., 2005) . The mechanisms explaining these associations are not well understood, although a proposed mechanistic explanation is that dietary calcium from dairies may suppress 1,25-dihydroxyvitamin D concentrations, thereby normalizing intracellular calcium concentration (Zemel, 1998) . Of note, the inverse association between dairy product intake and serum inflammatory marker concentrations persisted after adjustment for BMI, the presence of diabetes and calcium intake (data not shown). Since previous evidence derived from in vitro studies or in animal models had suggested that this association was unclear, our findings point to the need for further epidemiological, clinical and/or physiological studies addressing this issue.
Our study has some methodological limitations. One limitation may be measurement error (Michels, 2001) in the FFQs. That some associations may be overlooked when using this method has long been acknowledged (Kristal et al., 2005) . For example, associations between diet and cancer have been detected when dietary assessment was based on food records (Bingham et al., 2003) or biomarkers (Fowke et al., 2003) , but not when using FFQs (Kristal et al., 2005) . Although, the validity indices of our FFQ were within the standard range for validation studies (Martín-Moreno et al., 1993) , we acknowledge that misclassification bias in dietary assessment could have existed and might be an alternative explanation for our inability to detect more associations between the food items assessed and the markers of inflammation measured. This misclassification bias is even more likely when concentrations of inflammatory markers are measured in peripheral blood, as in the present study, rather than in specific tissues sites where they are produced in evaluating inflammation status. Indeed, a clear association was found in an observational study in which the inflammatory markers were measured in coronary sinus blood (Serrano-Martínez et al., 2005) . Also, there is a reasonable possibility that the score we have used might not be discriminatory enough of the adherence to the Mediterranean dietary pattern. However, a similar instrument was able to predict total and cardiovascular mortality (Trichopoulou et al., 2003) and the risk of myocardial infarction in Mediterranean populations (Martínez-González et al., 2004) . Another potential limitation is the design of the study as a randomized dietary intervention trial recruiting high-risk participants to test the hypothesis that enhancement of a Mediterranean-type diet for several years will reduce the incidence of cardiovascular events and could thus provide the highest level of clinical evidence on the benefits of the Mediterranean diet. However, the baseline crosssectional analysis of such a trial, well phenotyped for cardiovascular risk and with detailed dietary/nutrient intake data recorded, may be helpful if the results are in the direction of the hypothesis about the predicted effects of the intervention. Our results suggest that high customary intakes of the main components of the Mediterranean diet, such as olive oil, nuts, fruits and cereals, are associated with lower serum concentrations of inflammatory markers related to the occurrence and progression of atherosclerosis. These beneficial effects on intermediate biomarkers of cardiovascular risk do support the PREDIMED hypothesis and provide further evidence on the mechanisms by which some of the elements of a Mediterranean-type diet may prevent cardiovascular disease.
